Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2938)
All Articles published online
|
May 14, 2008 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Chen H, He YW, Liu WQ, Zhang JH. Rosiglitazone prevents murine hepatic fibrosis induced by |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i18/2905.htm |
| Number | Citing Articles |
| 1 |
Zheng Wang, Jia-Peng Xu, Yong-Chao Zheng, Wei Chen, Yong-Wei Sun, Zhi-Yong Wu, Meng Luo. Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats. Hepatobiliary & Pancreatic Diseases International 2011; 10(1): 64 doi: 10.1016/S1499-3872(11)60009-X
|
| 2 |
Naglaa Fathy Abd El-Aal, Rania Said Hamza, Ola Harb. Paeoniflorin targets apoptosis and ameliorates fibrosis in murine schistosomiasis mansoni : A novel insight. Experimental Parasitology 2017; 183: 23 doi: 10.1016/j.exppara.2017.10.005
|
| 3 |
Samar M. Alhusseiny, Samar N. El-Beshbishi, Maha M. Abu Hashim, Hosam El-dein E. El-nemr, Aya E. Handoussa. A comparative study on the anti-schistosomal and hepatoprotective effects of vinpocetine and isosorbide-5-mononitrate on Schistosoma mansoni -infected mice. Acta Tropica 2017; 176: 114 doi: 10.1016/j.actatropica.2017.07.016
|
| 4 |
Pengguo Chen, Jie Li, Yan Huo, Jin Lu, Lili Wan, Bin Li, Run Gan, Cheng Guo. Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis. PeerJ 2015; 3: e1518 doi: 10.7717/peerj.1518
|
| 5 |
Rehab M. El-Gharabawy, Amira S. Ahmed, Amal H. Al-Najjar. Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis. Biomedicine & Pharmacotherapy 2017; 85: 141 doi: 10.1016/j.biopha.2016.11.105
|
| 6 |
Virender Kumar, Vaibhav Mundra, Ram I. Mahato. Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis. Pharmaceutical Research 2014; 31(5): 1158 doi: 10.1007/s11095-013-1239-5
|
| 7 |
Yuanli Chen, Shu Yang, Lipei Liu, Xiaoxiao Yang, Yajun Duan, Shuang Zhang, Jihong Han. A novel therapy for hepatic cholestasis treatment—the combination of rosiglitazone and fenofibrate. European Journal of Pharmacology 2023; 938: 175428 doi: 10.1016/j.ejphar.2022.175428
|
| 8 |
Naglaa El-Lakkany, Sayed Seif el-Din, Fatma Ebeid. The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni. Experimental Parasitology 2011; 129(2): 152 doi: 10.1016/j.exppara.2011.06.015
|
| 9 |
Samah M. Ahmed, Shaimaa Ali Abdelrahman, Alaa Elsayed Salama. Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats. Ultrastructural Pathology 2017; 41(2): 168 doi: 10.1080/01913123.2017.1281367
|
| 10 |
J. Emanuel Ramos de Carvalho, Milan T. Verwoert, Ilse M.C. Vogels, Eric A. Reits, Cornelis J.F. Van Noorden, Ingeborg Klaassen, Reinier O. Schlingemann. Involvement of the ubiquitin-proteasome system in the expression of extracellular matrix genes in retinal pigment epithelial cells. Biochemistry and Biophysics Reports 2018; 13: 83 doi: 10.1016/j.bbrep.2018.01.005
|
| 11 |
Naglaa Fathy Abd El-Aal, Eman Hassan Abdelbary. Paeoniflorin in experimental BALB/c mansoniasis: A novel anti-angiogenic therapy. Experimental Parasitology 2019; 197: 85 doi: 10.1016/j.exppara.2018.11.002
|
| 12 |
Mohsen Mazidi, Ehsan Karimi, Mohsen Meydani, Majid Ghayour-Mobarhan, Gordon A Ferns. Potential effects of curcumin on peroxisome proliferator-activated receptor-γ<i> in vitro</i> and <i>in vivo</i>. World Journal of Methodology 2016; 6(1): 112-117 doi: 10.5662/wjm.v6.i1.112
|
| 13 |
Barrie J. Anthony, Jeremy T. Allen, Yuesheng S. Li, Donald P. McManus. A Role for Peroxisome Proliferator-Activated Receptors in the Immunopathology of Schistosomiasis?. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/128068
|
| 14 |
Dalia Kamal Mostafa, Maha M. Eissa, Doaa A. Ghareeb, Shaymaa Abdulmalek, Wafaa A. Hewedy. Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis. Inflammopharmacology 2024; 32(1): 763 doi: 10.1007/s10787-023-01382-y
|
| 15 |
Marion M. Chan, Kyle W. Evans, Andrea R. Moore, Dunne Fong. Peroxisome Proliferator-Activated Receptor (PPAR): Balance for Survival in Parasitic Infections. Journal of Biomedicine and Biotechnology 2010; 2010: 1 doi: 10.1155/2010/828951
|
| 16 |
Zheng Wang, Jiapeng Xu, Yongchao Zheng, Wei Chen, Yongwei Sun, Zhiyong Wu, Meng Luo. Effect of the regulation of retinoid X receptor‐α gene expression on rat hepatic fibrosis. Hepatology Research 2011; 41(5): 475 doi: 10.1111/j.1872-034X.2011.00794.x
|
| 17 |
Bhawana Singh, Sanjay Varikuti, Gregory Halsey, Greta Volpedo, Omar M Hamza, Abhay R Satoskar. Host-directed therapies for parasitic diseases. Future Medicinal Chemistry 2019; 11(15): 1999 doi: 10.4155/fmc-2018-0439
|
| 18 |
Hongyan Liu, Xiao Gao, Ruixian Duan, Qiao Yang, Yaowen Zhang, Yongwei Cheng, Yan Guo, Wangxian Tang. Endocannabinoids anandamide and its cannabinoid receptors in liver fibrosis after murine schistosomiasis. Journal of Huazhong University of Science and Technology [Medical Sciences] 2009; 29(2): 182 doi: 10.1007/s11596-009-0209-y
|
| 19 |
Georg Wick, Cecilia Grundtman, Christina Mayerl, Thomas-Florian Wimpissinger, Johann Feichtinger, Bettina Zelger, Roswitha Sgonc, Dolores Wolfram. The Immunology of Fibrosis. Annual Review of Immunology 2013; 31(1): 107 doi: 10.1146/annurev-immunol-032712-095937
|
| 20 |
Jia Liu, Qinyu Yao, Xinya Xie, Qi Cui, Tingting Jiang, Ziwei Zhao, Xiong Du, Baochang Lai, Lei Xiao, Nanping Wang. Procyanidin B2 Attenuates Nicotine-Induced Hepatocyte Pyroptosis through a PPARγ-Dependent Mechanism. Nutrients 2022; 14(9): 1756 doi: 10.3390/nu14091756
|
| 21 |
Jingjing Li, Chuanyong Guo, Jianye Wu. The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis. Drug Design, Development and Therapy 2021; : 2619 doi: 10.2147/DDDT.S310163
|
| 22 |
Yasmeen M Attia, Essam F Elalkamy, Olfat A Hammam, Soheir S Mahmoud, Aiman S El-Khatib. Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection. Parasites & Vectors 2013; 6(1) doi: 10.1186/1756-3305-6-199
|
| 23 |
Jayne Louise Wilson, Hannah Katharina Mayr, Thomas Weichhart. Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02265
|
| 24 |
Pengguo Chen, Jie Li, Yan Huo, Jin Lu, Lili Wan, Quanjun Yang, Jinlu Huang, Run Gan, Cheng Guo. Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats. Scientific Reports 2016; 6(1) doi: 10.1038/srep33593
|
| 25 |
Su Xu, Bin Jiang, Hui Wang, Cunsi Shen, Hao Chen, Li Zeng. Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition. Evidence-Based Complementary and Alternative Medicine 2017; 2017: 1 doi: 10.1155/2017/7876064
|
| 26 |
Wei Su, Yang Tai, Shi-Hang Tang, Yan-Ting Ye, Chong Zhao, Jin-Hang Gao, Bi-Guang Tuo, Cheng-Wei Tang. Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats. World Journal of Gastroenterology 2020; 26(28): 4094-4107 doi: 10.3748/wjg.v26.i28.4094
|
| 27 |
Heba H. Bakery, Gamal A. Allam, Abdelaziz S. A. Abuelsaad, Mahmoud Abdel‐Latif, Ayman E. Elkenawy, Rehab G. Khalil. Anti‐inflammatory, antioxidant, anti‐fibrotic and schistosomicidal properties of plumbagin in murine schistosomiasis. Parasite Immunology 2022; 44(11) doi: 10.1111/pim.12945
|
| 28 |
Barrie J. Anthony, Grant A. Ramm, Donald P. McManus. Role of resident liver cells in the pathogenesis of schistosomiasis. Trends in Parasitology 2012; 28(12): 572 doi: 10.1016/j.pt.2012.09.005
|
| 29 |
Sahil Mahajan, Ankita Saini, Rashi Kalra, Pawan Gupta. Frienemies of infection: A chronic case of host nuclear receptors acting as cohorts or combatants of infection. Critical Reviews in Microbiology 2016; 42(4): 526 doi: 10.3109/1040841X.2014.970122
|
| 30 |
M. BROWN. Parasites as aetiological agents in chronic diseases. Epidemiological associations and potential mechanisms of pathogenesis. Parasite Immunology 2009; 31(11): 653 doi: 10.1111/j.1365-3024.2009.01153.x
|
| 31 |
B.R. Prashantha Kumar, Nasir R. Baig, Sai Sudhir, Koyal Kar, M. Kiranmai, M. Pankaj, Nanjan M. Joghee. Discovery of novel glitazones incorporated with phenylalanine and tyrosine: Synthesis, antidiabetic activity and structure–activity relationships. Bioorganic Chemistry 2012; 45: 12 doi: 10.1016/j.bioorg.2012.08.002
|
| 32 |
Yuxiao Zhu, Yangyue Ni, Ran Liu, Min Hou, Bingya Yang, Jingwei Song, Hongzhi Sun, Zhipeng Xu, Minjun Ji. PPAR-γAgonist Alleviates Liver and Spleen Pathology via Inducing Treg Cells duringSchistosoma japonicumInfection. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/6398078
|
| 33 |
Feng Zhang, Desong Kong, Yin Lu, Shizhong Zheng. Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside. Cellular and Molecular Life Sciences 2013; 70(2): 259 doi: 10.1007/s00018-012-1046-x
|
| 34 |
Jihan A. Youssef, Mostafa Z. Badr. Peroxisome Proliferator-Activated Receptors. 2013; : 33 doi: 10.1007/978-1-62703-420-3_5
|
| 35 |
Michael Trauner, Emina Halilbasic. Nuclear Receptors as New Perspective for the Management of Liver Diseases. Gastroenterology 2011; 140(4): 1120 doi: 10.1053/j.gastro.2011.02.044
|